-
1
-
-
17044386953
-
Type 2 diabetes: Principles of pathogenesis and therapy
-
Stumvoll, M.; Golstein, B. J.; van Haften, T. W. Type 2 diabetes: principles of pathogenesis and therapy Lancet, 2005, 365, 1333-1345.
-
(2005)
Lancet
, vol.365
, pp. 1333-1345
-
-
Stumvoll, M.1
Golstein, B.J.2
van Haften, T.W.3
-
2
-
-
0034641568
-
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
-
Stratton, I. M.; Adler, A. I.; Neil, A. W.; Matthews, D. R.; Manley, S. E.; Cull, C. A.; Hadden, D.; Turner, R. C.; Holman, R. R. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study BMJ, 2000, 321, 405-412.
-
(2000)
BMJ
, vol.321
, pp. 405-412
-
-
Stratton, I.M.1
Adler, A.I.2
Neil, A.W.3
Matthews, D.R.4
Manley, S.E.5
Cull, C.A.6
Hadden, D.7
Turner, R.C.8
Holman, R.R.9
-
3
-
-
18044376795
-
PPARs: Therapeutic targets for metabolic disease
-
Berger, J. P.; Akiyama, T. E.; Meinke, P. T. PPARs: therapeutic targets for metabolic disease Trends Pharmacol. Sci., 2005, 26, 244-251.
-
(2005)
Trends Pharmacol. Sci
, vol.26
, pp. 244-251
-
-
Berger, J.P.1
Akiyama, T.E.2
Meinke, P.T.3
-
4
-
-
3843079807
-
Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 Diabetes
-
Henke, B. R. Peroxisome Proliferator-Activated Receptor α/γ Dual Agonists for the Treatment of Type 2 Diabetes J. Med. Chem., 2004, 47, 4118-4127.
-
(2004)
J. Med. Chem
, vol.47
, pp. 4118-4127
-
-
Henke, B.R.1
-
5
-
-
33750511973
-
PPARα and PPARγ dual agonists for the treatment of type 2 diabetes and the metabolic syndrome
-
a) Fiévet, C.; Fruchart, J.-C.; Staels, B. PPARα and PPARγ dual agonists for the treatment of type 2 diabetes and the metabolic syndrome Curr. Opin. Pharmacol., 2006, 6, 606-614;
-
(2006)
Curr. Opin. Pharmacol
, vol.6
, pp. 606-614
-
-
Fiévet, C.1
Fruchart, J.-C.2
Staels, B.3
-
6
-
-
34547625616
-
-
Shearer, B. G.; Billin, A. N The next generation of PPAR drugs: Do we have the tools to find them? Biochim. Biophys. Acta, 2007, 1771, 1082-1093 and references therein.
-
b) Shearer, B. G.; Billin, A. N The next generation of PPAR drugs: Do we have the tools to find them? Biochim. Biophys. Acta, 2007, 1771, 1082-1093 and references therein.
-
-
-
-
7
-
-
24344502706
-
Synthesis of new carbo-and heterocyclic analogues of 8-HETE and evaluation of their activity towards the PPARs
-
Caijo, F.; Mosset, P.; Grée, R.; Audinot-Bouchez, V.; Boutin, J.; Renard, P.; Caignard, D.-H.; Dacquet, C. Synthesis of new carbo-and heterocyclic analogues of 8-HETE and evaluation of their activity towards the PPARs Bioorg. Med. Chem. Lett., 2005, 15, 4421-4426.
-
(2005)
Bioorg. Med. Chem. Lett
, vol.15
, pp. 4421-4426
-
-
Caijo, F.1
Mosset, P.2
Grée, R.3
Audinot-Bouchez, V.4
Boutin, J.5
Renard, P.6
Caignard, D.-H.7
Dacquet, C.8
-
8
-
-
33646407834
-
Synthesis of aromatic analogues of 8(S)-HETE and their biological evaluation as activators of the PPARs nuclear receptors
-
a) Caijo, F.; Mosset, P.; Grée, R.; Audinot-Bouchez, V.; Boutin, J.; Renard, P.; Caignard, D.-H.; Dacquet, C. Synthesis of aromatic analogues of 8(S)-HETE and their biological evaluation as activators of the PPARs nuclear receptors Eur. J. Org. Chem., 2006, 2181-2196;
-
(2006)
Eur. J. Org. Chem
, pp. 2181-2196
-
-
Caijo, F.1
Mosset, P.2
Grée, R.3
Audinot-Bouchez, V.4
Boutin, J.5
Renard, P.6
Caignard, D.-H.7
Dacquet, C.8
-
9
-
-
58049201265
-
-
Grée, R, Liutkus, M, Caijo, F, Brioche, J, Jennequin, T, Dacquet, C, Ktorza, A, Caignard, D.-H. Preparation of heterocycles, in particular 3, alkynyl(hydroxy) methyl]-2-phenylalkoxyquinolines, pharmaceutical compositions containing them, and their use in the treatment of type II diabetes and obesity Patent PCT WO 2008081096
-
b) Grée, R.; Liutkus, M.; Caijo, F.; Brioche, J.; Jennequin, T.; Dacquet, C.; Ktorza, A.; Caignard, D.-H. Preparation of heterocycles, in particular 3-[(alkynyl)(hydroxy) methyl]-2-phenylalkoxyquinolines, pharmaceutical compositions containing them, and their use in the treatment of type II diabetes and obesity Patent PCT WO 2008081096.
-
-
-
-
10
-
-
0030952937
-
-
Forman, B. M.; Chen, J.; Evans, Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ R. M. Proc. Natl. Acad. Sci. USA, 1997, 94, 4312-4317.
-
Forman, B. M.; Chen, J.; Evans, Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ R. M. Proc. Natl. Acad. Sci. USA, 1997, 94, 4312-4317.
-
-
-
-
11
-
-
0006132932
-
Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ Proc
-
Kliewer, S. A.; Sundseth, S. S.; Jones, S. A.; Brown, P. J.; Wisely, G. B.; Koble, C. S.; Devchand, P.; Wahli, W.; Willson, T. M.; Lenhard, J. M.; Lehmann, J. M. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ Proc. Natl. Acad. Sci. USA, 1997, 94, 4318-4323.
-
(1997)
Natl. Acad. Sci. USA
, vol.94
, pp. 4318-4323
-
-
Kliewer, S.A.1
Sundseth, S.S.2
Jones, S.A.3
Brown, P.J.4
Wisely, G.B.5
Koble, C.S.6
Devchand, P.7
Wahli, W.8
Willson, T.M.9
Lenhard, J.M.10
Lehmann, J.M.11
-
12
-
-
0030985318
-
Fatty acids eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay
-
Krey, G.; Braissant, O.; L'Horset, F.; Kalkhoven, E.; Perroud, M.; Parker, M. G.; Wahli, W. Fatty acids eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol. Endocrinol., 1997, 11, 779-791.
-
(1997)
Mol. Endocrinol
, vol.11
, pp. 779-791
-
-
Krey, G.1
Braissant, O.2
L'Horset, F.3
Kalkhoven, E.4
Perroud, M.5
Parker, M.G.6
Wahli, W.7
-
13
-
-
0037430564
-
Amphipathic 3-Phenyl-7-propylbenzisoxazoles; human pPaR γ, δ and α agonists
-
Adams, A. D.; Yuen, W.; Hu, Z.; Santini, C.; Jones, A. B.; MacNaul, K. L.; Berger, J. P.; Doebber, T. W.; Moller, D. E. Amphipathic 3-Phenyl-7-propylbenzisoxazoles; human pPaR γ, δ and α agonists. Bioorg. Med. Chem. Lett., 2003, 13, 931-935.
-
(2003)
Bioorg. Med. Chem. Lett
, vol.13
, pp. 931-935
-
-
Adams, A.D.1
Yuen, W.2
Hu, Z.3
Santini, C.4
Jones, A.B.5
MacNaul, K.L.6
Berger, J.P.7
Doebber, T.W.8
Moller, D.E.9
-
14
-
-
0015921954
-
-
Corey, E. J.; Sachdev, H. S. Simple synthesis of 8-methylprostaglandin C2. J. Am. Chem. Soc., 1973, 95, 8483-8484.
-
Corey, E. J.; Sachdev, H. S. Simple synthesis of 8-methylprostaglandin C2. J. Am. Chem. Soc., 1973, 95, 8483-8484.
-
-
-
-
15
-
-
0001676136
-
Alkylation reactions of propargyl alcohol. Improved routes to prostaglandin α-side chain precursors
-
Casy, G.; Furber, M.; Richardson, K. A.; Stephenson, G. R.; Taylor, R. J. K. Alkylation reactions of propargyl alcohol. Improved routes to prostaglandin α-side chain precursors. Tetrahedron, 1986, 42, 5849-5856.
-
(1986)
Tetrahedron
, vol.42
, pp. 5849-5856
-
-
Casy, G.1
Furber, M.2
Richardson, K.A.3
Stephenson, G.R.4
Taylor, R.J.K.5
-
16
-
-
0000281301
-
Synthesis of some bioactive acetylenic alcohols, components of the marine sponge Cribrochalina vasculum
-
Kulkarni, B. A.; Chattopadhyay, S.; Chattopadhyay, A.; Mamdapur V. R. Synthesis of some bioactive acetylenic alcohols, components of the marine sponge Cribrochalina vasculum J. Org. Chem., 1993, 58, 5964-5966.
-
(1993)
J. Org. Chem
, vol.58
, pp. 5964-5966
-
-
Kulkarni, B.A.1
Chattopadhyay, S.2
Chattopadhyay, A.3
Mamdapur, V.R.4
-
17
-
-
0242636466
-
Quinoxalin-2-ones Part 5. Synthesis and antimicrobial evaluation of 3-alkyl-, 3-halomethyl-and 3-carboxyethylquinoxaline-2-ones variously substituted on the benzo-moiety
-
Carta, A.; Longa, M.; Zanetti, S.; Sechi, L. A. Quinoxalin-2-ones Part 5. Synthesis and antimicrobial evaluation of 3-alkyl-, 3-halomethyl-and 3-carboxyethylquinoxaline-2-ones variously substituted on the benzo-moiety Il Farmaco, 2003, 58, 1251-1255.
-
(2003)
Il Farmaco
, vol.58
, pp. 1251-1255
-
-
Carta, A.1
Longa, M.2
Zanetti, S.3
Sechi, L.A.4
-
18
-
-
37049154748
-
Syntheses of 2-mono-and 2,3-disubstituted quinoxalines
-
Gowenlock, A. H.; Newbold, G. T.; Spring, F. S. Syntheses of 2-mono-and 2,3-disubstituted quinoxalines J. Chem. Soc., 1945, 622-625.
-
(1945)
J. Chem. Soc
, pp. 622-625
-
-
Gowenlock, A.H.1
Newbold, G.T.2
Spring, F.S.3
-
19
-
-
0035815269
-
Binding of prostaglandins to human PPARγ: Tool assessment and new natural ligands
-
Ferry G.; Bruneau V.; Beauverger P.; Goussard M.; Rodriguez M.; Lamamy V. O.; Dromaint S.; Canet E.; Galizzi J. P.; Boutin J. A. Binding of prostaglandins to human PPARγ: tool assessment and new natural ligands. Eur. J. Pharmacol., 2001, 417, 77-89.
-
(2001)
Eur. J. Pharmacol
, vol.417
, pp. 77-89
-
-
Ferry, G.1
Bruneau, V.2
Beauverger, P.3
Goussard, M.4
Rodriguez, M.5
Lamamy, V.O.6
Dromaint, S.7
Canet, E.8
Galizzi, J.P.9
Boutin, J.A.10
-
20
-
-
0032565868
-
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
-
Staels, B.; Koenig, W.; Habib, A.; Merval, R.; Lebret, M.; Torra, I.P.; Delerive, P.; Fadel, A.; Chinetti, G.; Fruchart, J.C.; Najib, J.; Maclouf, J.; Tedgui, A. Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators Nature, 1998, 393, 790-793.
-
(1998)
Nature
, vol.393
, pp. 790-793
-
-
Staels, B.1
Koenig, W.2
Habib, A.3
Merval, R.4
Lebret, M.5
Torra, I.P.6
Delerive, P.7
Fadel, A.8
Chinetti, G.9
Fruchart, J.C.10
Najib, J.11
Maclouf, J.12
Tedgui, A.13
|